Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease
HT Greinix, B Volc-Platzer, RM Knobler - Leukemia & Lymphoma, 2000 - Taylor & Francis
Advances in posttransplanl immunosuppression have to the present not been able to
prevent the development of graft-versus-host disease (GVHD) in patients given related or …
prevent the development of graft-versus-host disease (GVHD) in patients given related or …
Extracorporeal photopheresis: an efficacious and well-tolerated treatment for cutaneous and oral mucosal chronic graft-versus-host disease
C Richet, A Huynh, C Dimeglio, C Borel, B Lepage… - Dermatology, 2018 - karger.com
Background: Extracorporeal photopheresis (ECP) is a second-line therapy for steroid-
refractory chronic graft-versus-host disease (cGVHD). Objective: We describe the long-term …
refractory chronic graft-versus-host disease (cGVHD). Objective: We describe the long-term …
PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease
K Ghoreschi, P Thomas, M Penovici, J Ullmann… - European Journal of …, 2008 - jle.com
Chronic graft-versus-host disease (GVHD) is almost always associated with skin diseases
appearing either as lichenoid GVHD, sclerodermatous GVHD (sGVHD) or as eosinophilic …
appearing either as lichenoid GVHD, sclerodermatous GVHD (sGVHD) or as eosinophilic …
Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy
M Grundmann-Kollmann, S Behrens, C Gruss… - Journal of the American …, 2000 - Elsevier
Graft-versus-host disease is a frequent complication of allogenic bone marrow
transplantation. Approximately 10% of patients suffering from chronic graft-versus-host …
transplantation. Approximately 10% of patients suffering from chronic graft-versus-host …
[HTML][HTML] Evidence-based, skin-directed treatments for cutaneous chronic graft-versus-host disease
YJ Kim, GH Lee, BY Kwong, KJ Martires - Cureus, 2019 - ncbi.nlm.nih.gov
Chronic graft-versus host disease (cGVHD) occurs in 30% to 70% of patients undergoing
allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of …
allogeneic hematopoietic cell transplantation (HCT). Cutaneous cGVHD affects 75% of …
Graft-versus-host disease
EW Cowen - Clinical and Basic Immunodermatology, 2008 - Springer
Over 15,000 patients per year are treated with allogeneic stem cell transplantation as an
intervention for cancer, primary immunodeficiency, and other serious heritable and acquired …
intervention for cancer, primary immunodeficiency, and other serious heritable and acquired …
A Pediatric Case of Sclerodermatous Graft‐Versus‐Host Disease Responsive to Ultraviolet A1 Phototherapy
L Lazzeri, L Tripo, L Pescitelli, F Ricceri… - Pediatric …, 2016 - Wiley Online Library
Graft‐versus‐host disease (GVHD) is one of the major complications after hematopoietic
stem cell transplantation and is responsible for post‐therapeutic morbidity, mortality, and …
stem cell transplantation and is responsible for post‐therapeutic morbidity, mortality, and …
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease
T Furlong, W Leisenring, R Storb, C Anasetti… - Biology of Blood and …, 2002 - tctjournal.org
Psoralen plus ultraviolet A irradiation (PUVA) has immunomodulatory effects and is used to
treat a variety of immune-mediated dermatologic diseases. We administered PUVA to 103 …
treat a variety of immune-mediated dermatologic diseases. We administered PUVA to 103 …
Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and …
FM Foss, GM DiVenuti, K Chin, K Sprague… - Bone marrow …, 2005 - nature.com
We enrolled 25 patients with extensive, steroid-refractory chronic graft-versus-host disease
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …
(cGVHD) in a prospective trial evaluating the efficacy of extracorporeal photophoresis (ECP) …
[引用][C] Chronic graft‐versus‐host disease: successful treatment with extracorporeal photochemotherapy: a follow‐up
A Konstantinow, BR Balda, H Starz… - British Journal of …, 1996 - academic.oup.com
StR. In cbronic graft-versus-bost (GVH) disease cytotoxic and suppressor T lymphocytes
probably play the decisive pathogenetic role.'Conventional immunosuppressive therapy is …
probably play the decisive pathogenetic role.'Conventional immunosuppressive therapy is …